Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Parafibromin immunohistochemistry enables the late diagnosis of parathyroid cancer
Australian and New Zealand Journal of Surgery, 05/04/09
Suliburk JW et al. – Data suggest that diagnosis of parathyroid cancer may well be missed due to lack of clear histological criteria. Parafibromin immunohistochemistry (PI) in selected cases of parathyroid tumours will enable the accurate diagnosis of parathyroid carcinoma.
Methods- Aim was to examine the impact of PI on achieving a late diagnosis of parathyroid cancer
- A case series with data obtained from the University of Sydney Endocrine Surgical Unit database is presented
- PI was performed on the cases identified
- 3 pts had initial diagnosis of parathyroid adenoma; subsequent PI enabled a late diagnosis of parathyroid carcinoma
- Mean age and sex distribution of 3 pts at initial diagnosis was 38.3 yrs, M : F 2:1
- Mean delay in diagnosis was 22 yrs
- No differences in patient age, sex distribution, serum calcium, and tumour weight between the 3 pts and all other pts who have undergone parathyroidectomy for primary hyperparathyroidism
- At follow-up:
- 1 patient appears cured with a normal serum calcium
- 1 has permanent hypoparathyroidism, and
- 1 has persistent hypercalcaemia with control of serum calcium by Cinacalcet therapy
Related Articles
A phase 2 trial exploring the effects of high-dose (10,000 IU/day) Vitamin D3 in breast cancer patients with bone metastases
Cancer, 11/18/09
Relevance Score: 66%
Diffuse Sclerosing Variant Is a Major Subtype of Papillary Thyroid Carcinoma in the Young
Thyroid, 11/06/09
Relevance Score: 66%
Phase I Clinical Trials in 56 Patients with Thyroid Cancer: The M. D. Anderson Cancer Center Experience
Journal of Clinical Endocrinology and Metabolism, 10/15/09
Relevance Score: 66%
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
Thyroid, 10/30/09
Relevance Score: 65%
Geographical correlation between incidence of benign disease and that of cancer of the thyroid among the population of the Rhone-Alpes region of France
European Journal of Endocrinology, 10/14/09
Relevance Score: 65%
Today in Endocrine Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
A Case of Advanced Medullary Thyroid Carcinoma Successfully Treated with Sunitinib
The Oncologist, 12/02/09
Clinical inquiry: What's the best way to monitor low-risk patients with a history of differentiated thyroid cancer?
The Journal of Family Practice, 12/02/09
Nonradiation Risk Factors for Thyroid Cancer in the US Radiologic Technologists Study
American Journal of Epidemiology, 12/02/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


